Bayer

ESC 2021: Bayer's Kerendia touts outcomes data as it looks to complement J&J, AZ drugs
Fierce Pharma
Sat, 08/28/21 - 09:02 pm
Bayer
ESC
finerenone
Kerendia
FDA
clinical trials
kidney disease
J&J, Bayer's Xarelto scores FDA nod in post-surgery artery disease as partners try to catch up with Eliquis
Fierce Pharma
Tue, 08/24/21 - 10:54 pm
Pfizer
Bristol Myers Squibb
Bayer
JNJ
Xarelto
FDA
Eliquis
Novartis says trials back Beovu safety in diabetic eye disease
Pharmaforum
Tue, 08/17/21 - 10:08 am
Novartis
Beovu
diabetic macular edema
Bayer
Regeneron
Eylea
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
Tue, 08/10/21 - 11:12 pm
M&A
Bayer
Sanofi
Amgen
uniQure
MorphoSys
Xeris Pharmaceuticals
Relay Therapeutics
Merck
Beam Therapeutics
Jazz Pharmaceuticals
Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3
Fierce Biotech
Thu, 08/5/21 - 11:11 am
Bayer
Vividion
M&A
IPOs
R&D
Chasing Merck & Co, Bayer builds case for cough drug eliapixant
Pharmaforum
Wed, 08/4/21 - 10:49 am
Bayer
Merck
chronic cough
eliapixant
gefapixant
clinical trials
Drugs facing the most patent expirations this year
Drug Patent Watch
Sun, 08/1/21 - 11:46 pm
patents
Novartis
Sunovion
Allergan
Bayer
Gilead Sciences
Bayer's drug that turns a cancer-protective pathway toxic eradicates breast tumors in mice
Fierce Biotech
Wed, 07/21/21 - 08:44 pm
Bayer
breast cancer
Systems Oncology
ErSO
FDA gives speedy review to Bayer’s Parkinson’s stem cell therapy
Pharmaforum
Tue, 07/20/21 - 11:14 am
Bayer
BlueRock Therapeutics
FDA
DA01
stem cells
Parkinson's Disease
FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro
RAPS.org
Thu, 07/15/21 - 12:34 pm
FDA
drug approvals
Bayer
Kerendia
Astellas
Padcev
Teva Pharmaceutical
ArmonAir RespiClick
Janssen
Darzalex Faspro
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Bayer
finerenone
Kerendia
kidney disease
heart disease
diabetes
type 2 diabetes
Farxiga
After selling its spinout to Bayer in a $875M-plus deal, NeRRe Therapeutics grabs $28M for some 'unfinished business'
Endpoints
Wed, 07/7/21 - 10:58 am
NeRRe
Bayer
M&A
Mary Kerr
KaNDy Therapeutics
AskBio, Syndax and Catalyst All on the Fast Track
BioSpace
Mon, 06/28/21 - 06:56 pm
FDA
fast track status
AskBio
Bayer
gene therapy
LGMD
Syndax Pharma
leukemia
Catalyst Biosciences
episodic bleeding
In surprising flop, Exelixis' Cabometyx combo with Roche's Tecentriq fails to extend life in liver cancer
Fierce Pharma
Mon, 06/28/21 - 10:50 am
Exelixis
Cabometyx
liver cancer
Bayer
Nexavar
'We're Not Gonna Take It'—Bayer and Twisted Sister rocker join nonprofit to push back on prostate cancer
Fierce Pharma
Fri, 06/18/21 - 10:10 am
Bayer
pharma marketing
prostate cancer
GSK, Bayer stand by CureVac following 'disappointing' COVID-19 vaccine trial flop
Fierce Pharma
Thu, 06/17/21 - 10:44 pm
CureVac
Bayer
GSK
vaccines
COVID19
Bayer pledges $300M to boost production in world's 'contraceptive capital’
Fierce Pharma
Sat, 06/12/21 - 10:25 pm
Bayer
Europe
drug manufacturing
contraceptives
Bayer's billon-dollar Parkinson's disease bets land in the clinic
Fierce Biotech
Tue, 06/8/21 - 11:15 am
Bayer
Parkinson's Disease
DA01
BlueRock Therapeutics
Bayer at ASCO: Vitrakvi Effective in TRK Fusion Cancers Regardless of Tumor Type
BioSpace
Sun, 06/6/21 - 10:31 pm
Bayer
ASCO 2021
Vitrakvi
cancer
Bayer picks up radiotherapeutics biotech to prop up dwindling sales in prostate cancer program
Fierce Biotech
Thu, 06/3/21 - 10:50 am
Bayer
radiotherapeutics
Noria Therapeutics
M&A
PSMA Therapeutics

Pages